Drug adverse event reports (FAERS)

Dysphagia, Neck pain, Oropharyngeal pain +10

Drugs: STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT

SeriousHospitalizationLife-threateningDisability
Safetyreportversion
1
Safetyreportid
27298918
Primarysourcecountry
US
Transmissiondateformat
102
Transmissiondate
20261010
Reporttype
1
Serious
1
Seriousnessdeath
2
Seriousnesslifethreatening
1
Seriousnesshospitalization
1
Seriousnessdisabling
1
Seriousnesscongenitalanomali
2
Seriousnessother
1
Receivedateformat
102
Receivedate
20260917
Receiptdateformat
102
Receiptdate
20260917
Fulfillexpeditecriteria
3
Authoritynumb
849430
Primarysource
Reportercountry
US
Qualification
5
Sender
Sendertype
6
Senderorganization
FDA-CTU
Receiver
Receivertype
6
Receiverorganization
FDA
Patient
Patientonsetage
49
Patientonsetageunit
801
Patientsex
2
Reaction
  1. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Dysphagia
  2. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Neck pain
  3. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Oropharyngeal pain
  4. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Muscular weakness
  5. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Respiratory failure
  6. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Cardio-respiratory arrest
  7. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Botulism
  8. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Myasthenia gravis
  9. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Guillain-Barre syndrome
  10. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Asthenia
  11. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Impaired work ability
  12. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Visual impairment
  13. +1 more not shown
Drug
  1. Drugcharacterization
    1
    Medicinalproduct
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT
    Drugbatchnumb
    Unknown
    Drugdosagetext
    OTHER QUANTITY : 2 INJECTION(S)?OTHER FREQUENCY : ONE-TIME INJECTION?OTHER ROUTE : INJECTED INTO TEMPORAL REGION, APPROXIMA
    Drugadministrationroute
    050
    Drugindication
    Stem cell therapy
    Drugstartdateformat
    102
    Drugstartdate
    20250602
    Drugenddateformat
    102
    Drugenddate
    20250602
    Drugadditional
    2
    Activesubstance
    Activesubstancename
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCTS
Summary
Narrativeincludeclinical
CASE EVENT DATE: 20250602
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.